Mobix Labs Files Definitive Proxy Statement
Ticker: MOBXW · Form: DEF 14A · Filed: Dec 18, 2024 · CIK: 1855467
| Field | Detail |
|---|---|
| Company | Mobix Labs, Inc (MOBXW) |
| Form Type | DEF 14A |
| Filed Date | Dec 18, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $0.00001, $1.06 |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, semiconductors
Related Tickers: MOBX
TL;DR
MOBX proxy statement filed. Shareholders vote on company matters.
AI Summary
Mobix Labs, Inc. filed a definitive proxy statement (DEF 14A) on December 18, 2024. The filing concerns the company's annual meeting and related matters. Mobix Labs, Inc. is a semiconductor company incorporated in Delaware with its principal office in Irvine, California.
Why It Matters
This filing provides shareholders with essential information regarding company governance, executive compensation, and voting matters, enabling informed participation in the company's decision-making processes.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing, which is standard for public companies and does not inherently indicate new risks.
Key Players & Entities
- MOBIX LABS, INC. (company) — Registrant
- Chavant Capital Acquisition Corp. (company) — Former Company Name
- 15420 Laguna Canyon Road, Suite 100 (location) — Business Address
- Irvine, CA (location) — Business City and State
FAQ
What is the purpose of this DEF 14A filing?
This filing is a Definitive Proxy Statement filed by Mobix Labs, Inc. for the United States Securities and Exchange Commission, pursuant to Section 14(a) of the Securities Exchange Act of 1934.
When was this filing submitted?
The filing was submitted on December 18, 2024.
What is the company's former name?
The company's former name was Chavant Capital Acquisition Corp., with a date of name change on April 6, 2021.
What is Mobix Labs, Inc.'s primary business classification?
Mobix Labs, Inc. is classified under SEMICONDUCTORS & RELATED DEVICES [3674].
Where is Mobix Labs, Inc. headquartered?
Mobix Labs, Inc.'s business address is 15420 Laguna Canyon Road, Suite 100, Irvine, CA 92618.
Filing Stats: 4,672 words · 19 min read · ~16 pages · Grade level 11.2 · Accepted 2024-12-18 16:48:59
Key Financial Figures
- $0.00001 — mber of shares of Class A common stock, $0.00001 par value per share (the “Class A
- $1.06 — Estimated based on the closing price of $1.06 for our Class A Common Stock on the Nas
Filing Documents
- formdef14a.htm (DEF 14A) — 591KB
- formpre14a_001.jpg (GRAPHIC) — 12KB
- proxycard_001.jpg (GRAPHIC) — 1482KB
- proxycard_002.jpg (GRAPHIC) — 973KB
- 0001493152-24-050622.txt ( ) — 3988KB
From the Filing
DEF 14A 1 formdef14a.htm UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to §240.14a-12 MOBIX LABS, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a–6(i)(1) and 0–11 MOBIX LABS, INC. 15420 Laguna Canyon Road, Suite 100 Irvine, California 92618 NOTICE OF SPECIAL MEETING OF STOCKHOLDERS   TO BE HELD ON JANUARY 3, 2025 Dear Stockholders of Mobix Labs, Inc.: You are cordially invited to attend a Special Meeting of Stockholders (including any adjournment, postponement or rescheduling thereof, the “Special Meeting”) of Mobix Labs, Inc., a Delaware corporation (“Mobix Labs,” the “Company,” “our,” “us,” or “we”), which will be held on January 3, 2025 at 9:00 a.m. Pacific Time. The Special Meeting will be held in a virtual meeting format only, via live audio webcast. Stockholders will not be able to attend the Special Meeting in person. To attend the Special Meeting virtually, please visit www.cstproxy.com/mobixlabs/2025. The live audio webcast will begin promptly at 9:00 a.m. Pacific Time, with online access beginning at 8:45 a.m. Pacific Time. If you plan to attend the Special Meeting, please refer to the attendance and registration information in the accompanying proxy statement (the “Proxy The Special Meeting will be held for the purpose of voting upon the following four proposals (each of which is a “Proposal,” and collectively, the “Proposals”): Proposal 1: Proposal to approve the grants of restricted stock awards and restricted stock units made outside of the Company’s 2023 Equity Incentive Plan to certain officers and employees and the non-employee directors of the Company, each pursuant to a separate award agreement. For further information regarding Proposal 1, please refer to page 6 of this Proxy Statement (the “Equity Grant Proposal”). THE BOARD RECOMMENDS VOTING “FOR” PROPOSAL 1. Proposal 2: Proposal to amend the Company’s 2023 Equity Incentive Plan to increase the number of shares of Class A common stock, $0.00001 par value per share (the “Class A Common Stock”) reserved for issuance under the 2023 Equity Incentive Plan from 2,290,183 to 10,600,000, all of which may be subject to incentive stock option award grants (the “Amendment”). For further information regarding Proposal 2, please refer to page 7 of this Proxy Statement (the “Equity Incentive Plan Amendment Proposal”). THE BOARD RECOMMENDS VOTING “FOR” PROPOSAL 2. Proposal 3: Proposal to approve the exercise of warrants issued by the Company to private investment in public equity (“PIPE”) investors in connection with our business combination that closed on December 21, 2023 to purchase up to an aggregate of 1,750,000 shares of Class A Common Stock under Nasdaq Listing Rule 5635(d). For further information regarding Proposal 3, please refer to page 17 of this Proxy Statement (the “2023 Warrant Exercise Proposal”). THE BOARD RECOMMENDS VOTING “FOR” PROPOSAL 3. Proposal 4 : Proposal to approve the exercise of the warrants issued by the Company on July 24, 2024 to purchase up to an aggregate of 5,956,835 shares of Class A Common Stock under Nasdaq Listing Rule 5635(d). For further information regarding Proposal 4, please refer to page 18 of this Proxy Statement (the “2024 Warrant Exercise Proposal”). THE BOARD RECOMMENDS VOTING “FOR” PROPOSAL 4. Proposal 5 : Proposal to amend our Certificate of Incorporation, as amended (the “Charter”) to remove restrictions on the ability of our holders of Class A Common Stock to take action by written consent. For further information regarding Proposal 5, please refer to page 20 of this Proxy Statement (the “Certificate of Incorporation Amendment Proposal”). THE BOARD RECOMMENDS VOTING “FOR” PROPOSAL 5. Each Proposal is more fully described in the Proxy Statement accompanying this notice. This Notice of Special Meeting, the accompanying Proxy Statement and the form of proxy are first being mailed on or about December 18, 2024 to stockholders of record as of December 16, 2024 (the “Record D